Teva Pharmaceuticals has been developing and producing medicines to help improve people’s lives for more than a century. We are committed to being a global leader in generic and specialty medicines with a portfolio of 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day. They are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products. Learn more at www.tevapharm.com.
Please note that adverse effects for any of our products should be reported to: Safety.AE@teva.co.il
Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here:
http://www.tevapharm.com/contact_us/
generic medicines, specialty medicines, CNS, active pharmaceutical ingredients, respiratory, biosimilars, biologics, pain care, migraine, and oncology
Teva Pharmaceutical Industries Ltd.
Entity | Type | Tweets | Articles | |
---|---|---|---|---|
vismedia.agency entertainment, Media Production | Other 31 Jul 2021 | | ||
Health Partners International Canada (HPIC) healthtech, Non-profit Organizations | Other 28 Feb 2022 | | ||
PMFarma Writing and Editing | Other 25 Jul 2022 | | ||
Airobotics Smart City, manufacturing, Industry 4.0, Aviation and Aerospace Component Manufacturing, Drones | Other 14 Aug 2022 | | ||
Sqilline IT Services, IT Services and IT Consulting | Other 19 Sep 2022 | | ||
AKT Global HRtech, Business Consulting and Services | Other 21 Sep 2022 | | ||
Egualia – Industrie Farmaci Accessibili biotech, deeptech, Pharmaceutical Manufacturing | Other 9 Oct 2022 | | ||
SAP Signavio Consulting, Software Development | Other 15 Oct 2022 | | ||
NeurologyLive healthtech, Online Audio and Video Media | Not capitalistic Not partnership Event 24 Oct 2022 | | ||
aMoon Fund Venture Capital and Private Equity Principals | Other 25 Oct 2022 | |